Clinical study of uterine
Leiomyoma and its associated risk factors
Sunita Sudhir P1, Madhavi
N2, Nissy Jacintha3
1Dr Sunita Sudhir P, Associate Professor, 2Dr Madhavi N, Professor, 3Dr
Nissy Jacintha, Assistant Professor, all authors are affiliated with
Department of Obstetrics and Gynaecology, Kamineni Institute of Medical
Sciences, Narketpally, Telangana State, India
Address for
Correspondence: Dr Sunita Sudhir. P, Associate Professor,
Department of Obstetrics and Gynaecology, Kamineni Institute of Medical
Sciences, Narketpally, Telangana State, India. E-mail:
sunitadr@rediffmail.com
Abstract
Introduction:
Uterine leiomyomas have historically been viewed as major indication
for hysterectomy. As new therapies have developed, the heterogeneity of
this disease has become therapeutically relevant. An awareness of the
role of risk factors, growth factors, hormones and genetics in tumor
etiology is the key to understanding of this disease. This study was
undertaken to know the various risk factors associated with uterine
leiomyoma. Objective:
To Study the clinical features and various risk factors associated with
leiomyoma of uterus. Materials
and Methods: This is a hospital based prospective study of
55 uterine leiomyoma cases. After taking consent all cases were
enrolled into the study and detailed history regarding mode of
presentation, clinical features and various risk factors of uterine
leiomyoma was taken, all cases underwent transvaginal ultrasound to
know the location of leiomyoma. Specimen of leiomyoma was sent for
histopathological examination and analysed. Results: Mean age group of
the cases was between 41 – 50 years. Mean age at menarche was
12.9 years. Maximum numbers of cases were in the group of PARA
– 2. Abnormal uterine bleeding like Menorrhagia,
Polymenorrhea, Metrorrhagia, and Dysmenorrhea were the most common
modes of presentation followed by pain and increased urinary frequency.
In the present study 49.09% of subjects were above normal BMI range.
Individuals with sedentary life style were at higher risk of developing
leiomyoma. Intramural was the commonest location of fibroid followed by
subserosal and submucus fibroids. On Histopathological examination,
leiomyoma was confirmed and Cervicitis was the most common accompanying
feature followed by adenomyoisis and degeneration. Conclusion:
Leiomyoma of uterus is multifactorial in origin with various factors
acting in conjunction. Increased oestrogen exposures due to factors
modulate myometrial cells and act as tumor promoters. Reproductive age
of patient, early menarche, obesity and parity are most common risk
fctors which modulate estrogen response.
Keywords:
Uterine Leiomyoma, Menorrhagia, Dysmenorrhia, Cervicitis, Adenomyosis
Degeneration
Manuscript received: 7th
December 2016, Reviewed:
15th December 2016
Author Corrected:
24th December 2016,
Accepted for Publication: 31st December 2016
Introduction
Leiomyoma or uterine fibroids are the most common benign solid tumors
to afflict women during their reproductive years. In spite of high
prevalence, fibroids still remain enigmatic, incidence and progression
of which is incompletely understood. Fibroids are the most frequent
indication for hysterectomy, causing enormous health and financial
burden.
Less than 50% patients with fibroids are symptomatic. As fibroids can
occur at various sites like Intramural, subserous, submucus, symptoms
due to fibroid uterus may be single or multiple depending upon the
size, site, numbers and concomitant degenerative changes in fibroid
[1,2]. Even though they are benign, fibroids cause reproductive
problems such as, heavy and abnormal uterine bleeding, uterine
enlargement, pelvic pressure, severe cramping pain, infertility and
miscarriages thus causing substantial morbidity. It is however
surprising that no significant data is still available to give a clear
idea as to what is the major cause of fibroids [3, 4].
The incidence of uterine fibroids increases as women grow old, and they
may occur in more than 30 percent of women between the age group of 40
to 60 years. Risk factors include nulliparity, obesity, family history,
black race, and hypertension. Leiomyomas can occur at various
anatomical sites, uterus being the commonest of all and in the uterus
it can be, intramural, submucus, subserosal, and cervical [5]. Clinical
sequel of leiomyomas depend on their location in the uterus, may be
associated with irregular bleeding, intermenstrual bleeding, causing
anemia, leiomyomas also have been associated with abortion, preterm
labour infertility. 0.1% of cases go in for malignant change known as
leiomyo sarcoma [3,4].
Aims
and Objectives
1. To study the clinical features of uterine leiomyoma
2. To identify the risk factors associated with leiomyoma
uterus.
Materials
and Methods
Study Design:
Prospective observational study.
Study Sample: 55
Place Of Study:
Kamineni institute of medical sciences , Narketpally.
Inclusion Criteria
1) Women in reproductive age group diagnosed to have fibroid uterus by
ultrasonography.
2) Patient having menorrhagia secondary to fibroid uterus.
3) Patient undergoing hysterectomy or myomectomy for fibroid uterus.
4) Patient willing to give consent for enrolment in the study.
Exclusion Criteria
1) Patients having other pelvic pathologies.
2) Patients on hormonal replacement therapy (HRT).
3) Patients on treatment for carcinomas eg. breast cancer.
4) Postmenopausal women having fibroid
Methodology:
Selected patients were informed about the study, written consent was
taken and then enrolled into the study. Clinical presentation and risk
factors, were analyzed by taking detailed medical, personal and family
history in a specifically designed proforma. Patients were subjected to
investigations like transvaginal ultrasonography scan to confirm the
location of fibroid, surgical profile. All patients were managed with
appropriate surgery according to standard hospital protocol. Post
surgery the hysterectomy/ myomectomy specimen was sent for
histopathological examination and leiomyoma confirmed.
Results
Age: In the
present study all the patients were in the range of 25 -55 years.
Maximum numbers of patients were in the age group of 41 - 50 years,
accounting for 63% of all cases. Youngest patient in our study was of
29 years age oldest patient in our study was of age 54 years.
Mean age of the patients was:- 44 years ; SD(σ) =
±5.81
Table No 1: Age Group
Distribution (n=55)
Age group
|
No. of patients
N = 55
|
%
|
25 -30
|
1
|
1.81
|
31 – 35
|
5
|
9.09
|
36 – 40
|
9
|
16.36
|
41 – 45
|
14
|
25.45
|
46 – 50
|
21
|
38.18
|
>50
|
6
|
10.90
|
Menarche:
Mean age at menarche was: 12.927 years; SD (σ) = ±
0.74
Menarche Age range was: 10 -16 years
Parity: 30
(54.54%) cases were in para 2 group, followed by14 (25.45%) cases of
para 3 group. Woman of highest parity was of para 6 and in the group of
para 1 there were 6 cases.
Combined total of Para – 1 and Para – 2 cases
accounted for of 65.45%.of cases.
ie (P1 =6) + (P2 = 30) = 36 /55 x 100
Table No.-2:
Clinical Presentation
Presentation
|
No. of cases
|
Menstrual Symptoms
|
47(85.45%)
|
Pain Abdomen
|
8(14.54%)
|
Mass Per Abdomen
|
6(10.90%)
|
Urinary Symptoms
|
5(9.09%)
|
Most common mode of presentation was related to menstrual symptoms. 47
cases presented with menstrual symptoms and 8 cases presented with
history of pain abdomen.
Table No 3: Menstrual
Symptoms (n=47)
Menorrhagia
|
26 (47.27%)
|
Metrorrhagia
|
3 (5.4%)
|
Polymenorrhea
|
7 (12.7%)
|
Dysmenorrhea
|
5 (9.09%)
|
Intermenstrual Bleeding
|
6 (10.90%)
|
Out of 47 patients who had menstrual symptoms, menorrhagia (47.27%) was
the most common type of menstrual irregularity observed.
Duration of Symptoms: In our study duration of the disease with respect
to chief complaints was evaluated.
Table No 4: Duration of
Symptoms (n=55)
Duration of symptoms
|
No. of cases
|
< 1 Month
|
3
|
1 – 3 Month
|
5
|
3 – 6 Months
|
13
|
6 – 9 Months
|
9
|
9 – 12 Months
|
8
|
1 – 2 Years
|
12
|
> 2 Years
|
5
|
It was observed that most of the patients presented to Gynaecology OPD
between 3 months to 1 year. Some patients presented late due to
symptomatic management of menstrual symptoms with local doctors.
Ignorance and lack of awareness also plays an important role in time
duration of disease and presentation of case.
Smoking: In
our study none of the patients had history of smoking.
Obesity: We
correlated the incidence of fibroid and obesity with respect to Body
Mass Index (BMI). BMI was calculated by using body weight and height.
BMI = Weight (In Kg)/ Height2 (In Meters) .
Obesity was graded as:
Normal: BMI 18.5 – 24.99
Over weight: BMI 25 - 29.99
Obese: BMI > 30
Table No 5: Obesity
Obesity
|
No. of Patients
|
Normal
|
28 (50.9%)
|
Over weight
|
17 (30.90%)
|
Obese
|
10 (18.18%)
|
In our study 50.9% of patients, were with in normal range of BMI.
49.08% of cases crossed the normal BMI range
OCP Use: OCP
use has been linked with the incidence of fibroid. In our study 5 out
of 55(9.09%) cases gave history of OCP use, and all of the above were
irregular users and Details of most commonly used OCP were unavailable.
Family History: Genetic
linkage with occurrence of fibroids has been widely accepted.In this
study 13 out of 55 patients had positive family history of fibroids.
And 5 patients had positive family history in their first degree
relatives.
Life Style: Sedentary
life style has been more commonly associated with leiomyoma uterus. In
the present study 60% of cases had sedentary life style remaining 40%
of cases were leading an active life style.
Ultrasound Examination: All
selected cases under went transvaginal ultrasound for confirmation of
leiomyoma, distribution and location of fibroids was noted. Intramural
location was the most common site of fibroids seen in 48(87.27%) cases,
in 4(7.2%) cases fibroid was subserosal and in 3(5.4%) cases submucosal
in location. Out of 55 cases studied 32 cases had solitary fibroid and
22 cases had multiple fibroids.
Histopathological
Examination: In all cases, leiomyoma was confirmed by
histopathological examination of the hysterectomy /myomectomy specimen.
Associated histopathological findings were noted. Cervicitis was the
most common histopathological change associated with fibroids, seen in
27 cases followed by adenomyosis and degenerative changes.
Table No 6: Associated
Histopathological changes. (n=55)
Histopathology
|
n = 55 (%)
|
Adenomyosis
|
18(32.70%)
|
Cervicitis
|
27(49.09%)
|
Degenerative changes
|
10(18.18%)
|
Discussion
This is a prospective case control study in which a total of 55 cases
with uterine leiomyoma and 55 age matched controls, free of uterine
leiomyoma were studied. All cases underwent routine surgical work up,
detailed history was taken in all cases with respect to reproductive
factors, risk factors, and cases were treated as per surgical protocol.
Surgical specimen was sent for histopathological examination. Data
collected during the study was analysed.
Age- In our
study 63% of patients were in the age group of 41-50years. Mean age at
presentation was of 44 years SD (σ) ± 5.81. It was
similar to an earlier study conducted by Faerestein et al (2001) where
mean age at presentation was 43.3 years and maximum patients were in
the age group of 40-49 years [6].
Menarche:
Mean age at menarche of cases in our study was 12.9 years which was
almost similar to that of Faerestein et al(2001) [6] where mean age of
menarche was 12.4 years.
Parity: In
present study it was found that most of the women were of para-2, 67%
of the cases were combined para - 1 and para - 2. One case of para
– 6 was found to have a strong positive family history.
Faerestein et al(2001) [6] observed 55% of cases in para 1 and Para 2
group, the difference in this percentage might be attributed to the
smaller sample size we studied.
Presentation:
In our study menstrual symptoms like menorrhagia, metrorrhagia,
polymenorrhagia, dysmenorrhea were the most common presenting symptoms
seen in 85.45% of cases. Among menstrual symptoms, menorrhagia was the
most common presenting symptom seen in 26 cases (47.27%), followed by
pain abdomen (14.54%), urinary symptoms (10.90%) and mass per abdomen
(9.09%). An earlier study of Nuruddin et al(2002) [7] Similarly
observed abnormal uterine bleeding as the most common presenting
symptom in fibroid patients , seen in 74.1% of cases followed by pain
seen in 29.3% of cases.
Duration of Symptoms: Most
of the patients presented within 3 months to 1 year of the onset of
symptoms. Late presenters were either having minimal symptoms or were
taking symptomatic treatment for abnormal uterine bleeding. In our
study we observed that patients with pain and increased urinary
frequency presented early as compared to those with menorrhagia. The
cases presented in this study much earlier than that reported by
Nuruddin et al (2002) [7] who observed 1 – 3 years as most
common mean duration of symptoms. Earlier presentation of cases in our
study could be due to increased awareness and education in the
population.
Obesity:
Obesity is considered to be risk factor for uterine leiomyoma. Shikora
et al.(1991) [8] in their study observed 51% of the hysterectomy- or
myomectomy-confirmed patients with leiomyomata were overweight, and 16%
were severely obese. In our study we correlated a similar incidence of
fibroid and obesity with respect to BMI and observed 50.9% of patients
with in normal range of BMI. 49.08% of cases crossed the normal BMI
range (30.9% overweight +18.18% Obese).
Smoking:
Several studies have revealed that smokers have reduced risk of
fibroids. (Michnovicz et al. 1986) [9]In our study none of the patients
gave history of smoking.
Family History:
Positive family history has been considered to have an increased
incidence of fibroids. In our study 13 out of 55 patients (23.63%) had
positive family history of fibroids and five of them had a first degree
relative with fibroids which is less when compared to the study
conducted by Schwartz et al.(2000b) [10] where 638 patients were
studied and 33.2% of patients had a positive family history of
fibroids. This difference may be because older family members of women
in our cohort were not screened for gynaecological disorders.
Life Style:
Sedentary life style is more commonly associated with leiomyoma uterus.
Frisch et al.( 1985) [11] and Wyshak et al.( 1986) [12] reported that
patients having an active life style have a less chance of developing
fibroids as compared to Patients, leading a sedentary life style.
Similar history was observed in our study where 60% of cases had a
sedentary life style.
Ultrasound Examination:
Nuruddin et al (2002) [7] found most common location of fibroids was
intramural (55.3%), followed by subserosal and least common was
submucus fibroid, while Faerestein et al(2001) [6] also observed
intramural location as a common site of fibroids, which was seen in
42.3% of cases followed by subserosal, where as we observed 87.27% of
fibroids in the intramural location followed by subserosal and
submucus, this difference in percentage in may be due to the smaller
sample size included in this study.
Histopathological
Examination: In all cases leiomyoma was confirmed by
histopathological examination and the most common accompanying feature
observed was cervicitis followed by adenomyosis and degeneration.
Nuruddin et al ( 2002) [7] also observed similar features in his study.
Overall this preliminary study of uterine leiomyomata or uterine
fibroids indicates that obesity, sedentary life style and family
history attribute to the risk of developing fibroids.
Conclusion
From this study we conclude that uterine leiomyoma is a disease of
complex etiology and multifactorial in origin, no single factor can be
pin pointed. Among all, Reproductive age of patient, early menarche,
obesity and parity play an important role in occurrence of uterine
leiomyoma, they act as promoters of the tumor. Basic pathology behind
these risk factors is that they increase the estrogen exposure of the
target uterine myometrium and may increase the number of cell divisions
resulting in increased chance of mutation in genes controlling
myometrial cell proliferation.
Funding:
Nil, Conflict of
interest: None initiated.
Permission from IRB:
Yes
References
1. Lesley LB, John AR, leiomyomatn uteri and myomectomy.Te lindes
operative gynaecology 9th edition; Lippincott Williams and wilkinsons
2003:753-798.
2. Lumsden MA, Wallace EM. Clinical presentation of uterine fibroids.
Baillieres Clin Obstet Gynaecol. 1998 Jun;12(2):177-95. [PubMed]
3. Sandberg AA. Updates on the cytogenetics and molecular genetics of
bone and soft tissue tumors: leiomyoma. Cancer Genet Cytogenet. 2005
Apr 1;158(1):1-26.
4. Cramer SF, Patel A. The frequency of uterine leiomyomas. Am J Clin
Pathol. 1990 Oct;94(4):435-8. [PubMed]
5. Flake, Gordon P, Janet Anderson, Darlene Dixon. Etiology
and pathogenesis of uterine leiomyoma -A review;
Environment health perspect 2003; 111: 1037 - 1054.
6. Farestien E, Moyses Szklo, Neil Rosenshein. Uterine leiomyoma
a practice based case control study -African American
heritage, reproductive history,body size and smoking. American Journal
of Epidemiology 2001;153(1):1- 10.
7. Mohammed NB, NoorAli R, AnandaKumar C. Uterine fibroid: clinical
presentation and relative morbidity of abdominal myomectomy and total
abdominal hysterectomy, in a teaching hospital of Karachi, Pakistan.
Singapore Med J. 2002 Jun;43(6):289-95.
8. Shikora SA, Niloff JM, Bistrian BR, Forse RA, Blackburn GL.
Relationship between obesity and uterine leiomyomata. Nutrition. 1991
Jul-Aug;7(4):251-5.
9. Michnovicz JJ, Hershcopf RJ, Naganuma H, Bradlow HL, Fishman J.
Increased 2-hydroxylation of estradiol as a possible mechanism for the
anti-estrogenic effect of cigarette smoking. N Engl J Med. 1986 Nov
20;315(21):1305-9. [PubMed]
10. Schwartz SM, Voigt L, Tickman E, Yarbro P, Daling J, Scholes
D. Familial aggregation of uterine leiomyomata. Am J
Epidemiol2000b; 151:5-10.
11. Frisch RE, Wyshak G, Albright NL, Albright TE, Schiff I, Jones KP,
Witschi J, Shiang E, Koff E, Marguglio M. Lower prevalence of breast
cancer and cancers of the reproductive system among former college
athletes compared to non-athletes. Br J Cancer. 1985 Dec;52(6):885-91.
12. Wyshak G, Frisch RE, Albright NL, Albright TE, Schiff I. Lower
prevalence of benign diseases of the breast and benign tumours of the
reproductive system among former college athletes compared to
non- athletes.Br J Cancer 1986;54:841–845.
How to cite this article?
Sunita Sudhir P, Madhavi N, Nissy Jacintha. Clinical study of uterine
Leiomyoma and its associated risk factors. Obg Rev:J obstet Gynecol
2016;2(4):65-70.doi: 10.17511/jobg.2016.i4.02.